These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 23851120)

  • 1. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
    Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups.
    Kaur M; Battisti RA; Ward PB; Ahmed A; Hickie IB; Hermens DF
    Schizophr Res; 2011 Aug; 130(1-3):203-9. PubMed ID: 21550211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations.
    Hermens DF; Ward PB; Hodge MA; Kaur M; Naismith SL; Hickie IB
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):822-9. PubMed ID: 20302901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory Mismatch Negativity and P300a Elicited by the "Optimal" Multi-feature Paradigm in Early Schizophrenia.
    Fisher DJ; Campbell DJ; Abriel SC; Ells EML; Rudolph ED; Tibbo PG
    Clin EEG Neurosci; 2018 Jul; 49(4):238-247. PubMed ID: 29502452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch negativity/P3a complex in young people with psychiatric disorders: a cluster analysis.
    Kaur M; Lagopoulos J; Ward PB; Watson TL; Naismith SL; Hickie IB; Hermens DF
    PLoS One; 2012; 7(12):e51871. PubMed ID: 23251645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurophysiological biomarkers support bipolar-spectrum disorders within psychosis cluster.
    Kaur M; Battisti RA; Lagopoulos J; Ward PB; Hickie IB; Hermens DF
    J Psychiatry Neurosci; 2012 Sep; 37(5):313-21. PubMed ID: 22469054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auditory mismatch negativity and P3a in response to duration and frequency changes in the early stages of psychosis.
    Nagai T; Tada M; Kirihara K; Yahata N; Hashimoto R; Araki T; Kasai K
    Schizophr Res; 2013 Nov; 150(2-3):547-54. PubMed ID: 24012461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatch negativity is a stronger indicator of functional outcomes than neurocognition or theory of mind in patients with schizophrenia.
    Lee SH; Sung K; Lee KS; Moon E; Kim CG
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():213-9. PubMed ID: 24161665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients.
    Light GA; Braff DL
    Arch Gen Psychiatry; 2005 Feb; 62(2):127-36. PubMed ID: 15699289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automatic sensory information processing abnormalities across the illness course of schizophrenia.
    Jahshan C; Cadenhead KS; Rissling AJ; Kirihara K; Braff DL; Light GA
    Psychol Med; 2012 Jan; 42(1):85-97. PubMed ID: 21740622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.
    Light GA; Swerdlow NR; Thomas ML; Calkins ME; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Pela M; Radant AD; Seidman LJ; Sharp RF; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Tsuang DW; Tsuang MT; Braff DL; Turetsky BI
    Schizophr Res; 2015 Apr; 163(1-3):63-72. PubMed ID: 25449710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological and electrophysiological indices of neurocognitive dysfunction in bipolar II disorder.
    Andersson S; Barder HE; Hellvin T; Løvdahl H; Malt UF
    Bipolar Disord; 2008 Dec; 10(8):888-99. PubMed ID: 19594504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-diagnostic comparison of duration mismatch negativity and P3a in bipolar disorder and schizophrenia.
    Jahshan C; Wynn JK; Mathis KI; Altshuler LL; Glahn DC; Green MF
    Bipolar Disord; 2012 May; 14(3):239-48. PubMed ID: 22548897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of mismatch negativity (MMN) and novelty P300 in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness.
    Fisher DJ; Smith DM; Labelle A; Knott VJ
    Biol Psychol; 2014 Jul; 100():43-9. PubMed ID: 24865523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis.
    Atkinson RJ; Michie PT; Schall U
    Biol Psychiatry; 2012 Jan; 71(2):98-104. PubMed ID: 22000060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced P3a amplitudes in antipsychotic naïve first-episode psychosis patients and individuals at clinical high-risk for psychosis.
    Mondragón-Maya A; Solís-Vivanco R; León-Ortiz P; Rodríguez-Agudelo Y; Yáñez-Téllez G; Bernal-Hernández J; Cadenhead KS; de la Fuente-Sandoval C
    J Psychiatr Res; 2013 Jun; 47(6):755-61. PubMed ID: 23507048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD.
    Rydkjær J; Møllegaard Jepsen JR; Pagsberg AK; Fagerlund B; Glenthøj BY; Oranje B
    Psychol Med; 2017 Jan; 47(2):377-388. PubMed ID: 27776572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMN and P3a Elicited by a Novelty Oddball Paradigm Are Not Reduced in Early-Phase Psychosis.
    Riel H; Rudolph E; MacPhee C; Tibbo PG; Fisher DJ
    Neuropsychobiology; 2022; 81(6):506-515. PubMed ID: 36380625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological performance and auditory event related potentials in schizophrenia patients and their siblings: a family study.
    Şevik AE; Anıl Yağcıoğlu AE; Yağcıoğlu S; Karahan S; Gürses N; Yıldız M
    Schizophr Res; 2011 Aug; 130(1-3):195-202. PubMed ID: 21592733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auditory event-related potentials, neurocognition, and global functioning in drug naïve first-episode schizophrenia and bipolar disorder.
    Li X; Deng W; Xue R; Wang Q; Ren H; Wei W; Zhang Y; Li M; Zhao L; Du X; Meng Y; Ma X; Hall MH; Li T
    Psychol Med; 2023 Feb; 53(3):785-794. PubMed ID: 34474699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.